Glenmede Trust’s GE HealthCare GEHC Stock Holding History

Glenmede Trust’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.02M	Sell	62,868 -34,962	-36%	-$2.3M	0.02%	487
2026 Q1	$6.96M	Buy	97,830 +72,045	+279%	+$5.68M	0.03%	401
2025 Q4	$2.11M	Buy	+25,785	New	+$2.01M	0.01%	561
2025 Q1	$1.17M	Sell	14,445 -1,270	-8%	-$109K	0.01%	662
2024 Q4	$1.23M	Sell	15,715 -14,458	-48%	-$1.23M	0.01%	654
2024 Q3	$2.83M	Buy	30,173 +180	+0.6%	+$15.1K	0.01%	511
2024 Q2	$2.34M	Buy	29,993 +2,525	+9%	+$206K	0.01%	534
2024 Q1	$2.5M	Sell	27,468 -4,260	-13%	-$354K	0.01%	530
2023 Q4	$2.45M	Buy	31,728 +3,420	+12%	+$240K	0.01%	512
2023 Q3	$1.93M	Sell	28,308 -3,438	-11%	-$250K	0.01%	524
2023 Q2	$2.6M	Hold	31,746	–	–	0.01%	475
2023 Q1	$2.6M	Buy	+31,746	New	+$2.27M	0.01%	476

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Glenmede Trust's GEHC Position: Q2 2026 in Review

Glenmede Trust reduced its GE HealthCare (GEHC) stake by 36% in Q2 2026, selling an estimated $2.3M and leaving 62,868 shares worth $4.02M. The position accounts for 0.02% of the portfolio, ranked #487.

Glenmede Trust first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $6.96M in Q1 2026. 1,227 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Glenmede Trust held 62,868 shares of GE HealthCare worth $4.02M as of Q2 2026.
Glenmede Trust sold 34,962 GE HealthCare shares in Q2 2026, an estimated $2.3M.
GE HealthCare made up 0.02% of Glenmede Trust's portfolio in Q2 2026, its #487 holding.
Glenmede Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
Glenmede Trust's GE HealthCare position peaked at $6.96M in Q1 2026.
1,227 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.